Product Code: VMR11218749
The global demand for Nucleic Acid Isolation & Purification Market is presumed to reach the market size of nearly USD 18.42 BN by 2030 from USD 8.9 BN in 2022 with a CAGR of 8.42% under the study period 2023 - 2030.
Nucleic acid isolation & purification is the basic process for most of the molecular biology techniques such as sequencing, cloning, polymerase chain reaction, among others. There are many extraction methods for the isolation and purification of nucleic acid from the cell debris. The method depends on various factors such as type of nucleic acid, source organism, desired result, etc. Post extrations, purification usually involves a combination of methods such as precipitation, chromatography, chromatography, centrifugation etc.
MARKET DYNAMICS:
The growing collaborations between various companies and organizations in the biotech industry drives the nucleic acid isolation & purification market. Besides, these nucleic acids are used in multiple applications like gene-splicing, forensics, bioscience research, and molecular diagnostics, promoting market growth. Moreover, governments across the globe are making huge investments in research and development work and technological innovations, triggering the expansion of the global nucleic acid isolation & purification market. Additionally, the development of personalized medicine is another important factor that drives revenue generation in the nucleic acid isolation & purification market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nucleic acid isolation & purification. The growth and trends of nucleic acid isolation & purification industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the nucleic acid isolation & purification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Kits
- Reagents
- Instruments
By Type
- Plasmid DNA Isolation And Purification
- Total RNA Isolation And Purification
- Circulating Nucleic Acid Isolation And Purification
- Genomic DNA Isolation And Purification
- Messenger RNA Isolation And Purification
- MicroRNA Isolation And Purification
- PCR Cleanup
- Other Nucleic Acid Isolation And Purification Types
By Method
- Column-Based Isolation And Purification
- Magnetic Bead-Based Isolation And Purification
- Reagent-Based Isolation And Purification
- Other Isolation And Purification Methods
By Application
- Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Agriculture & Animal Research
- Other Applications
By End User
- Hospitals & Diagnostic Centers
- Academic & Government Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Other End Users
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Nucleic Acid Isolation & Purification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Nucleic Acid Isolation & Purification market include QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), and Omega Bio-tek (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . NUCLEIC ACID ISOLATION & PURIFICATION - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Method
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End User
- 3.7.6 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY PRODUCT
- 6.1 Overview by Product
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Product
- 6.4 Kits Historic and Forecast Sales by Regions
- 6.5 Reagents Historic and Forecast Sales by Regions
- 6.6 Instruments Historic and Forecast Sales by Regions
7 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY TYPE
- 7.1 Overview by Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Type
- 7.4 Plasmid DNA Isolation And Purification Historic and Forecast Sales by Regions
- 7.5 Total RNA Isolation And Purification Historic and Forecast Sales by Regions
- 7.6 Circulating Nucleic Acid Isolation And Purification Historic and Forecast Sales by Regions
- 7.7 Genomic DNA Isolation And Purification Historic and Forecast Sales by Regions
- 7.8 Messenger RNA Isolation And Purification Historic and Forecast Sales by Regions
- 7.9 microRNA Isolation And Purification Historic and Forecast Sales by Regions
- 7.10. PCR Cleanup Historic and Forecast Sales by Regions
- 7.11 Other Nucleic Acid Isolation And Purification Types Historic and Forecast Sales by Regions
8 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY METHOD
- 8.1 Overview by Method
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Method
- 8.4 Column-based Isolation And Purification Historic and Forecast Sales by Regions
- 8.5 Magnetic Bead-based Isolation And Purification Historic and Forecast Sales by Regions
- 8.6 Reagent-based Isolation And Purification Historic and Forecast Sales by Regions
- 8.7 Other Isolation And Purification Methods Historic and Forecast Sales by Regions
9 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY APPLICATION
- 9.1 Overview by Application
- 9.2 Historical and Forecast Data
- 9.3 Analysis by Application
- 9.4 Diagnostics Historic and Forecast Sales by Regions
- 9.5 Drug Discovery & Development Historic and Forecast Sales by Regions
- 9.6 Personalized Medicine Historic and Forecast Sales by Regions
- 9.7 Agriculture & Animal Research Historic and Forecast Sales by Regions
- 9.8 Other Applications Historic and Forecast Sales by Regions
10 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY END USER
- 10.1 Overview by End User
- 10.2 Historical and Forecast Data
- 10.3 Analysis by End User
- 10.4 Hospitals & Diagnostic Centers Historic and Forecast Sales by Regions
- 10.5 Academic & Government Research Institutes Historic and Forecast Sales by Regions
- 10.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
- 10.7 Contract Research Organizations Historic and Forecast Sales by Regions
- 10.8 Other End Users Historic and Forecast Sales by Regions
11 . GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET ANALYSIS BY GEOGRAPHY
- 11.1. Top Company Share Analysis
- 11.2. Introduction
- 11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
- 11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
- 11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
- 11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
- 11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis
12 . COMPETITIVE LANDSCAPE OF THE NUCLEIC ACID ISOLATION & PURIFICATION COMPANIES
- 12.1. Nucleic Acid Isolation & Purification Market Competition
- 12.2. Partnership/Collaboration/Agreement
- 12.3. Merger And Acquisitions
- 12.4. New Product Launch
- 12.5. Other Developments
13 . COMPANY PROFILES OF NUCLEIC ACID ISOLATION & PURIFICATION INDUSTRY
- 13.1. Company Share Analysis
- 13.2. Market Concentration Rate
- 13.3. QIAGEN N.V. (NetherlAnds)
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
- 13.4. Thermo Fisher Scientific (US)
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
- 13.5. F. Hoffmann-La Roche Ltd. (SwitzerlAnd)
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
- 13.6. Merck KGaA (Germany)
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
- 13.7. Bio-Rad Laboratories (US)
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
- 13.8. Agilent Technologies (US)
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
- 13.9. Danaher Corporation (US)
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
- 13.10. GE Healthcare (US)
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
- 13.11. Illumina Inc. (US)
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
- 13.12. Takara Bio (Japan)
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments
- 13.13. Zymo Research (US)
- 13.13.1. Company Overview
- 13.13.2. Company Revenue
- 13.13.3. Products
- 13.13.4. Recent Developments
- 13.14. New EnglAnd Biolabs (US)
- 13.14.1. Company Overview
- 13.14.2. Company Revenue
- 13.14.3. Products
- 13.14.4. Recent Developments
- 13.15. Norgen Biotek Corp (Canada)
- 13.15.1. Company Overview
- 13.15.2. Company Revenue
- 13.15.3. Products
- 13.15.4. Recent Developments
- 13.16. Omega Bio-tek (US)
- 13.16.1. Company Overview
- 13.16.2. Company Revenue
- 13.16.3. Products
- 13.16.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies